Variant report
Variant | nsv980625 |
---|---|
Chromosome Location | chr5:29252358-29257987 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561668529 | chr5:29252362-29252363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561011083 | chr5:29252364-29252365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142406809 | chr5:29252397-29252398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146834420 | chr5:29252420-29252421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139633946 | chr5:29252439-29252440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371826435 | chr5:29252442-29252443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73750011 | chr5:29252449-29252450 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs538353241 | chr5:29252467-29252468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549069418 | chr5:29252547-29252548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566745230 | chr5:29252568-29252569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534098587 | chr5:29252586-29252587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556058776 | chr5:29252587-29252588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs70948517 | chr5:29252588-29252589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200464620 | chr5:29252600-29252601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186601320 | chr5:29252656-29252657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs71608748 | chr5:29252666-29252667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538278859 | chr5:29252714-29252715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537911371 | chr5:29252719-29252720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192614921 | chr5:29252808-29252809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs578037125 | chr5:29252817-29252818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184596289 | chr5:29252857-29252858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560538938 | chr5:29252869-29252870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572242550 | chr5:29252876-29252877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542437724 | chr5:29252885-29252886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561280419 | chr5:29252918-29252919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531495331 | chr5:29252924-29252925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10461855 | chr5:29252933-29252934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140309771 | chr5:29253016-29253017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144038800 | chr5:29253024-29253025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528851231 | chr5:29253065-29253066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557488935 | chr5:29253068-29253069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577292937 | chr5:29253108-29253109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs55696992 | chr5:29253116-29253117 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs146430655 | chr5:29253194-29253195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565420002 | chr5:29253217-29253218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs559702266 | chr5:29253252-29253253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs74622093 | chr5:29253277-29253278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534431844 | chr5:29253291-29253292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577518725 | chr5:29253349-29253350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs540532356 | chr5:29253375-29253376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567808059 | chr5:29253378-29253379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140689955 | chr5:29253405-29253406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150078743 | chr5:29253427-29253428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571686289 | chr5:29253435-29253436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145646422 | chr5:29253476-29253477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542788650 | chr5:29253487-29253488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148890614 | chr5:29253493-29253494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572446754 | chr5:29253500-29253501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7701380 | chr5:29253507-29253508 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs554475803 | chr5:29253515-29253516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29250400-29254800 | Weak transcription | Hela-S3 | cervix |
2 | chr5:29254800-29255000 | Enhancers | Hela-S3 | cervix |
3 | chr5:29255000-29255600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr5:29255000-29258600 | Weak transcription | Hela-S3 | cervix |
5 | chr5:29255200-29255400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr5:29255400-29257200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |